Prothena Historical Financial Ratios

PRTA Stock

USD 15.14 0.60 3.81%

Prothena Plc is promptly reporting on over 109 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as Book Value Per Share of 6.66, Invested Capital of 0.0, Average Payables of 0.0 or Stock Based Compensation To Revenue of 0.43 will help investors to properly organize and evaluate Prothena plc financial condition quickly.

Quick Ratio Current Ratio

Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Prothena plc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.

For information on how to trade Prothena Stock refer to our How to Trade Prothena Stock guide.

About Prothena Financial Ratios Analysis

Prothena plcFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate Prothena Plc investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on Prothena financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across Prothena Plc history.

Prothena Plc Financial Ratios Chart

At present, Prothena Plc's Days Sales Outstanding is projected to decrease significantly based on the last few years of reporting. The current year's Payables Turnover is expected to grow to 15.58, whereas Price To Sales Ratio is forecasted to decline to 20.11.

Price To Sales Ratio Days Sales Outstanding Roic Payables Turnover Capex To Revenue Price Earnings To Growth Ratio

Add Fundamental

Price To Sales Ratio

Price to Sales Ratio is figured by comparing Prothena plc stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Prothena Plc sales, a figure that is much harder to manipulate than other Prothena plc multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.

Roic

Return on Invested Capital, a profitability ratio that measures the return that an investment generates for those who have provided capital, such as debt holders and equity holders.

Payables Turnover

A liquidity ratio that shows how quickly a company pays off its suppliers by dividing total purchases by average accounts payable.

Capex To Revenue

The ratio of a company's capital expenditures to its total revenue, indicating how much of the revenue is used for acquiring or maintaining physical assets.

Most ratios from Prothena Plc's fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into Prothena plc current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Prothena plc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.

For information on how to trade Prothena Stock refer to our How to Trade Prothena Stock guide.At present, Prothena Plc's Days Sales Outstanding is projected to decrease significantly based on the last few years of reporting. The current year's Payables Turnover is expected to grow to 15.58, whereas Price To Sales Ratio is forecasted to decline to 20.11.

	2021	2023	2024 (projected)
Graham Number	18.95	25.61	16.12
Receivables Turnover	869.44	17.71	16.83

Graham Number Receivables Turnover

Prothena Plc fundamentals Correlations

	Price To Sales Ratio	Ptb Ratio	Days Sales Outstanding	Book Value Per Share	Free Cash Flow Yield	Operating Cash Flow Per Share	Capex To Depreciation	Pb Ratio	Ev To Sales	Free Cash Flow Per Share	Roic	Inventory Turnover	Net Income Per Share	Days Of Inventory On Hand	Payables Turnover	Average Inventory	Capex To Revenue	Cash Per Share	Pocfratio	Interest Coverage	Capex To Operating Cash Flow	Pfcf Ratio	Days Payables Outstanding	Income Quality	Roe	Ev To Operating Cash Flow
Price To Sales Ratio		-0.16	0.72	0.13	0.1	-0.29	0.07	-0.16	0.96	-0.32	0.16	0.14	-0.42	0.28	0.1	-0.26	0.69	-0.02	0.19	0.09	0.15	0.17	-0.2	-0.09	0.16	0.17
Ptb Ratio	-0.16		0.04	-0.54	0.01	0.21	0.87	1.0	-0.11	0.19	-1.0	0.09	0.28	-0.01	-0.06	-0.21	0.04	-0.25	0.07	-0.43	-0.26	0.07	-0.08	-0.01	-1.0	0.05
Days Sales Outstanding	0.72	0.04		0.06	-0.02	-0.28	0.25	0.04	0.81	-0.3	-0.03	0.25	-0.21	-0.06	-0.19	-0.35	0.35	-0.03	0.1	-0.13	0.06	0.08	-0.23	0.01	-0.03	0.06
Book Value Per Share	0.13	-0.54	0.06		0.33	-0.17	-0.43	-0.54	0.15	-0.16	0.53	-0.18	-0.15	-0.29	-0.18	0.11	0.06	0.77	-0.25	0.55	-0.06	-0.26	0.36	0.13	0.53	-0.25
Free Cash Flow Yield	0.1	0.01	-0.02	0.33		0.46	-0.1	0.01	0.13	0.44	-0.01	-0.39	0.34	-0.25	0.02	0.23	0.02	0.6	-0.25	0.53	-0.22	-0.25	0.16	-0.11	-0.01	-0.26
Operating Cash Flow Per Share	-0.29	0.21	-0.28	-0.17	0.46		-0.08	0.21	-0.32	1.0	-0.2	-0.69	0.87	-0.2	0.32	0.12	-0.31	0.16	-0.27	-0.01	-0.3	-0.24	-0.17	0.01	-0.2	-0.24
Capex To Depreciation	0.07	0.87	0.25	-0.43	-0.1	-0.08		0.87	0.18	-0.13	-0.87	0.19	0.0	-0.03	-0.21	-0.31	0.43	-0.24	0.12	-0.41	-0.23	0.12	-0.12	0.02	-0.87	0.1
Pb Ratio	-0.16	1.0	0.04	-0.54	0.01	0.21	0.87		-0.11	0.19	-1.0	0.09	0.28	-0.01	-0.06	-0.21	0.04	-0.25	0.07	-0.43	-0.26	0.07	-0.08	-0.01	-1.0	0.05
Ev To Sales	0.96	-0.11	0.81	0.15	0.13	-0.32	0.18	-0.11		-0.35	0.11	0.12	-0.36	0.16	-0.13	-0.32	0.73	0.06	0.15	0.03	0.1	0.13	-0.15	0.0	0.11	0.12
Free Cash Flow Per Share	-0.32	0.19	-0.3	-0.16	0.44	1.0	-0.13	0.19	-0.35		-0.19	-0.67	0.88	-0.2	0.32	0.13	-0.37	0.16	-0.27	-0.01	-0.28	-0.24	-0.16	0.01	-0.19	-0.24
Roic	0.16	-1.0	-0.03	0.53	-0.01	-0.2	-0.87	-1.0	0.11	-0.19		-0.09	-0.27	0.01	0.06	0.21	-0.04	0.25	-0.07	0.42	0.26	-0.07	0.08	0.01	1.0	-0.05
Inventory Turnover	0.14	0.09	0.25	-0.18	-0.39	-0.69	0.19	0.09	0.12	-0.67	-0.09		-0.6	-0.17	-0.17	-0.28	0.04	-0.35	-0.17	-0.21	-0.18	-0.21	0.14	-0.55	-0.09	-0.2
Net Income Per Share	-0.42	0.28	-0.21	-0.15	0.34	0.87	0.0	0.28	-0.36	0.88	-0.27	-0.6		-0.32	-0.11	0.21	-0.42	0.14	-0.32	-0.13	-0.33	-0.29	-0.05	0.24	-0.27	-0.3
Days Of Inventory On Hand	0.28	-0.01	-0.06	-0.29	-0.25	-0.2	-0.03	-0.01	0.16	-0.2	0.01	-0.17	-0.32		0.28	0.28	0.12	-0.35	0.86	0.02	0.82	0.87	-0.12	0.45	0.01	0.87
Payables Turnover	0.1	-0.06	-0.19	-0.18	0.02	0.32	-0.21	-0.06	-0.13	0.32	0.06	-0.17	-0.11	0.28		-0.03	-0.06	-0.19	0.18	0.12	0.17	0.18	-0.37	-0.38	0.06	0.21
Average Inventory	-0.26	-0.21	-0.35	0.11	0.23	0.12	-0.31	-0.21	-0.32	0.13	0.21	-0.28	0.21	0.28	-0.03		-0.31	0.15	0.23	0.6	0.37	0.24	0.32	0.37	0.21	0.24
Capex To Revenue	0.69	0.04	0.35	0.06	0.02	-0.31	0.43	0.04	0.73	-0.37	-0.04	0.04	-0.42	0.12	-0.06	-0.31		0.04	0.11	0.02	-0.07	0.1	-0.1	-0.06	-0.04	0.09
Cash Per Share	-0.02	-0.25	-0.03	0.77	0.6	0.16	-0.24	-0.25	0.06	0.16	0.25	-0.35	0.14	-0.35	-0.19	0.15	0.04		-0.19	0.5	-0.09	-0.2	0.6	0.19	0.25	-0.2
Pocfratio	0.19	0.07	0.1	-0.25	-0.25	-0.27	0.12	0.07	0.15	-0.27	-0.07	-0.17	-0.32	0.86	0.18	0.23	0.11	-0.19		-0.12	0.93	1.0	0.01	0.6	-0.07	1.0
Interest Coverage	0.09	-0.43	-0.13	0.55	0.53	-0.01	-0.41	-0.43	0.03	-0.01	0.42	-0.21	-0.13	0.02	0.12	0.6	0.02	0.5	-0.12		0.04	-0.12	0.21	-0.06	0.42	-0.11
Capex To Operating Cash Flow	0.15	-0.26	0.06	-0.06	-0.22	-0.3	-0.23	-0.26	0.1	-0.28	0.26	-0.18	-0.33	0.82	0.17	0.37	-0.07	-0.09	0.93	0.04		0.93	0.09	0.61	0.26	0.93
Pfcf Ratio	0.17	0.07	0.08	-0.26	-0.25	-0.24	0.12	0.07	0.13	-0.24	-0.07	-0.21	-0.29	0.87	0.18	0.24	0.1	-0.2	1.0	-0.12	0.93		-0.01	0.62	-0.07	1.0
Days Payables Outstanding	-0.2	-0.08	-0.23	0.36	0.16	-0.17	-0.12	-0.08	-0.15	-0.16	0.08	0.14	-0.05	-0.12	-0.37	0.32	-0.1	0.6	0.01	0.21	0.09	-0.01		0.16	0.08	-0.01
Income Quality	-0.09	-0.01	0.01	0.13	-0.11	0.01	0.02	-0.01	0.0	0.01	0.01	-0.55	0.24	0.45	-0.38	0.37	-0.06	0.19	0.6	-0.06	0.61	0.62	0.16		0.01	0.6
Roe	0.16	-1.0	-0.03	0.53	-0.01	-0.2	-0.87	-1.0	0.11	-0.19	1.0	-0.09	-0.27	0.01	0.06	0.21	-0.04	0.25	-0.07	0.42	0.26	-0.07	0.08	0.01		-0.05
Ev To Operating Cash Flow	0.17	0.05	0.06	-0.25	-0.26	-0.24	0.1	0.05	0.12	-0.24	-0.05	-0.2	-0.3	0.87	0.21	0.24	0.09	-0.2	1.0	-0.11	0.93	1.0	-0.01	0.6	-0.05

Click cells to compare fundamentals

Prothena Plc Account Relationship Matchups

High Positive Relationship

Pb Ratio	+ 1.0	Ptb Ratio
Free Cash Flow Per Share	+ 1.0	Operating Cash Flow Per Share
Roe	+ 1.0	Roic
Pfcf Ratio	+ 1.0	Pocfratio
Ev To Operating Cash Flow	+ 1.0	Pocfratio
Ev To Operating Cash Flow	+ 1.0	Pfcf Ratio

High Negative Relationship

Roe	- 1.0	Pb Ratio
Roic	- 1.0	Pb Ratio
Roe	- 1.0	Ptb Ratio
Roic	- 1.0	Ptb Ratio
Roe	- 0.87	Capex To Depreciation
Roic	- 0.87	Capex To Depreciation

Prothena Plc fundamentals Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Price To Sales Ratio	775.59	561.99	10.89	52.94	21.17	20.11
Ptb Ratio	2.31	2.61	4.69	4.59	3.44	3.27
Days Sales Outstanding	30.49	6.42	0.0237	0.42	20.61	28.75
Book Value Per Share	6.84	4.61	10.54	13.13	10.55	6.66
Free Cash Flow Yield	(0.0848)	(0.17)	0.0421	(0.0383)	(0.0707)	(0.0742)
Operating Cash Flow Per Share	(1.33)	(2.01)	2.09	(2.3)	(2.52)	(2.39)
Stock Based Compensation To Revenue	28.97	25.81	0.12	0.58	0.45	0.43
Capex To Depreciation	0.0814	0.0281	0.0845	0.62	3.03	2.64
Pb Ratio	2.31	2.61	4.69	4.59	3.44	3.27
Ev To Sales	342.2	236.62	8.07	39.89	14.52	13.8
Free Cash Flow Per Share	(1.34)	(2.02)	2.08	(2.31)	(2.57)	(2.7)
Roic	(0.37)	(0.49)	(0.31)	(0.59)	0.14	(0.19)
Net Income Per Share	(1.95)	(2.78)	1.51	(2.47)	(2.76)	(2.9)
Days Of Inventory On Hand	(0.49)	6.59	(0.0577)	(3.36)	(3.02)	(3.17)
Payables Turnover	40.93	18.19	22.29	0.73	8.69	15.58
Sales General And Administrative To Revenue	43.9	45.37	0.23	0.93	0.68	0.64
Research And Ddevelopement To Revenue	62.45	87.79	0.41	2.51	2.41	2.29
Capex To Revenue	0.68	0.23	0.002867	0.008608	0.0308	0.0292
Cash Per Share	9.42	7.4	13.09	15.0	11.63	8.79
Pocfratio	(11.92)	(5.97)	23.59	(26.23)	(14.44)	(15.16)
Capex To Operating Cash Flow	(0.0105)	(0.002439)	0.006209	(0.004264)	(0.021)	(0.022)
Pfcf Ratio	(11.8)	(5.95)	23.74	(26.12)	(14.15)	(14.85)
Days Payables Outstanding	8.92	20.07	16.37	501.94	42.02	55.98
Income Quality	0.68	0.72	1.38	0.93	0.91	0.6
Roe	(0.48)	(0.28)	(0.6)	0.14	(0.19)	(0.26)
Ev To Operating Cash Flow	(5.26)	(2.51)	17.47	(19.76)	(9.91)	(10.4)
Pe Ratio	(8.13)	(4.31)	32.62	(24.4)	(13.15)	(13.81)
Ev To Free Cash Flow	(1.04)	(5.2)	(2.51)	17.58	(19.67)	(10.19)
Intangibles To Total Assets	(0.006449)	(0.00406)	(0.002219)	(0.002918)	(0.003356)	(0.003524)
Net Debt To E B I T D A	4.47	2.5	(7.87)	5.35	3.19	3.03
Current Ratio	21.36	11.58	17.48	14.34	11.24	22.33
Tangible Book Value Per Share	6.91	4.64	10.57	13.18	10.55	6.69
Receivables Turnover	477.5	11.97	56.87	869.44	17.71	16.83
Graham Number	17.32	16.99	18.95	27.01	25.61	16.12
Shareholders Equity Per Share	6.84	4.61	10.54	13.13	10.55	6.66

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

C	Citigroup
GM	General Motors
F	Ford Motor

When determining whether Prothena plc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Prothena Plc's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Prothena Plc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Prothena Plc Stock:

How To Invest In Prothena

Details

Is Prothena Stock a good investment?

Details

What is Prothena Plc's Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

For information on how to trade Prothena Stock refer to our How to Trade Prothena Stock guide.

You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Prothena Plc. If investors know Prothena will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Prothena Plc listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(2.46)

Revenue Per Share

2.482

Quarterly Revenue Growth

(0.99)

Return On Assets

(0.16)

Return On Equity

(0.23)

The market value of Prothena plc is measured differently than its book value, which is the value of Prothena that is recorded on the company's balance sheet. Investors also form their own opinion of Prothena Plc's value that differs from its market value or its book value, called intrinsic value, which is Prothena Plc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Prothena Plc's market value can be influenced by many factors that don't directly affect Prothena Plc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Prothena Plc's value and its price as these two are different measures arrived at by different means. Investors typically determine if Prothena Plc is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Prothena Plc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Price To Sales Ratio	Dividend Yield
Ptb Ratio	Days Sales Outstanding
Book Value Per Share	Free Cash Flow Yield
Invested Capital	Operating Cash Flow Per Share
Average Payables	Stock Based Compensation To Revenue
Capex To Depreciation	Pb Ratio
Ev To Sales	Free Cash Flow Per Share
Roic	Inventory Turnover
Net Income Per Share	Days Of Inventory On Hand
Payables Turnover	Sales General And Administrative To Revenue
Average Inventory	Research And Ddevelopement To Revenue
Capex To Revenue	Cash Per Share
Pocfratio	Interest Coverage
Payout Ratio	Capex To Operating Cash Flow
Pfcf Ratio	Days Payables Outstanding
Net Current Asset Value	Income Quality
Roe	Tangible Asset Value
Ev To Operating Cash Flow	Pe Ratio
Return On Tangible Assets	Ev To Free Cash Flow
Earnings Yield	Intangibles To Total Assets
Net Debt To E B I T D A	Current Ratio
Tangible Book Value Per Share	Receivables Turnover
Graham Number	Shareholders Equity Per Share
Debt To Equity	Capex Per Share
Graham Net Net	Average Receivables
Revenue Per Share	Interest Debt Per Share
Debt To Assets	Enterprise Value Over E B I T D A
Short Term Coverage Ratios	Price Earnings Ratio
Operating Cycle	Price Book Value Ratio
Price Earnings To Growth Ratio	Days Of Payables Outstanding
Dividend Payout Ratio	Price To Operating Cash Flows Ratio
Price To Free Cash Flows Ratio	Pretax Profit Margin
Ebt Per Ebit	Operating Profit Margin
Effective Tax Rate	Company Equity Multiplier
Long Term Debt To Capitalization	Total Debt To Capitalization
Return On Capital Employed	Debt Equity Ratio
Ebit Per Revenue	Quick Ratio
Dividend Paid And Capex Coverage Ratio	Net Income Per E B T
Cash Ratio	Cash Conversion Cycle
Operating Cash Flow Sales Ratio	Days Of Inventory Outstanding
Days Of Sales Outstanding	Free Cash Flow Operating Cash Flow Ratio
Cash Flow Coverage Ratios	Price To Book Ratio
Fixed Asset Turnover	Capital Expenditure Coverage Ratio
Price Cash Flow Ratio	Enterprise Value Multiple
Debt Ratio	Cash Flow To Debt Ratio
Price Sales Ratio	Return On Assets
Asset Turnover	Net Profit Margin
Gross Profit Margin	Price Fair Value
Return On Equity

Prothena Historical Financial Ratios

About Prothena Financial Ratios Analysis

Prothena Plc Financial Ratios Chart

Price To Sales Ratio

Roic

Payables Turnover

Capex To Revenue

Prothena Plc fundamentals Correlations

Prothena Plc Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Prothena Plc fundamentals Accounts

Also Currently Popular

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY